![Chemical structure of N-(2,6-dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl}acetamide, CAS 95635-55-5](https://api.angenesci.com/structure/2147/95635-55-5.png)
无数据
无数据
无数据
| CAS Number | 95635-55-5 |
| Catalog Number | AG00H8QM(AGN-PC-0WAE7I) |
| Chemical Name | N-(2,6-dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl}acetamide |
| IUPAC Name | N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide |
| InChI | InChI=1S/C24H33N3O4/c1-18-7-6-8-19(2)24(18)25-23(29)16-27-13-11-26(12-14-27)15-20(28)17-31-22-10-5-4-9-21(22)30-3/h4-10,20,28H,11-17H2,1-3H3,(H,25,29) |
| InChI Key | XKLMZUWKNUAPSZ-UHFFFAOYSA-N |
| MDL Number | MFCD00864690 |
| Molecular Formula | C24H33N3O4 |
| Molecular Weight | 427.5365 |
| NSC Number | 759100 |
| SMILES | C1=C(C(=CC=C1)OC)OCC(CN3CCN(CC(NC2=C(C=CC=C2C)C)=O)CC3)O |
| Synonyms | 43285, RS,
Dihydrochloride, Ranolazine,
HCl, Ranolazine,
Hydrochloride, Ranolazine,
N-(2,6-dimethylphenyl)-4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)-1-piperazineacetamide,
Ranexa,
ranolazine,
Ranolazine Dihydrochloride,
Ranolazine HCl,
Ranolazine Hydrochloride,
renolazine,
RS 43285,
RS 43285 193,
RS 43285-193,
RS 43285193,
RS-43285,
RS43285,
RANOLAZINE,
95635-55-5,
Ranexa,
N-(2,6-dimethylphenyl)-2-(4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)piperazin-1-yl)acetamide,
CVT-303,
(-)-Ranolazine,
Ranolazine (Ranexa),
RS-43285-003,
N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide,
142387-99-3,
CHEBI:87690,
N-(2,6-dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl}acetamide,
CVT 303,
C24H33N3O4,
NCGC00015897-02,
DSSTox_CID_25196,
DSSTox_RID_80743,
DSSTox_GSID_45196,
Ran4,
Latixa,
RAN D,
N-(2,6-dimethylphenyl)-4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)-1-piperazineacetamide,
N-(2,6-DIMETHYLPHENYL)-4-[2-HYDROXY-3-(2-METHOXYPHENOXY)PROPYL]-1-PIPERAZINEACETAMIDE,
(+-)-Ranolazine,
CAS-95635-55-5,
Ranexa (TN),
SR-01000076216,
Ranolazine (USAN/INN),
Ranolazine [USAN:INN:BAN],
HSDB 7924,
1-Piperazineacetamide, N-(2,6-dimethylphenyl)-4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)-,
1-Piperazineacetamide, N-(2,6-dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-,
Ranolazine(Ranexa),
KEG-1295,
(+/-)-Ranolazine,
AC1Q5LYD,
CHEMBL1404,
Lopac0_001062,
BSPBio_002276,
MLS002154149,
SCHEMBL124665,
SPECTRUM1505366,
AC1L1M17,
GTPL7291,
DTXSID3045196,
CTK3I7295,
XKLMZUWKNUAPSZ-UHFFFAOYSA-N,
HMS1922F16,
HMS2090L09,
HMS2093D21,
HMS2098K06,
HMS2230C19,
HMS3369I08,
HMS3655M12,
HMS3715K06,
Pharmakon1600-01505366,
ACT06286,
BCP04190,
HY-B0280,
KS-00000JS7,
Tox21_110258,
BDBM50173335,
CR0012,
MFCD00864690,
NSC759100,
s1799,
AKOS015889500,
Tox21_110258_1,
AC-1673,
AN-5494,
BCP9000558,
CCG-205139,
CS-2292,
DB00243,
KS-1244,
MCULE-8182023610,
NSC-759100,
PB21724,
SB13209,
NCGC00015897-03,
NCGC00015897-04,
NCGC00015897-05,
NCGC00015897-06,
NCGC00015897-08,
NCGC00095177-01,
NCGC00095177-02,
NCGC00095177-03,
4CA-1078,
AK-72950,
BC205445,
BR-72950,
H959,
SC-25810,
SMR000857382,
BCP0726000090,
SBI-0051032.P002,
AB0007809,
AB2000299,
LS-187267,
TR-031802,
FT-0601594,
ST24025536,
SW197620-4,
CVT 303;RS 43285-003,
D05700,
RS 43285-003,
S-1794,
AB00698532-11,
AB00698532-13,
AB00698532-14,
AB00698532-15,
AB00698532_16,
AB00698532_17,
AB00698532_18,
635R555,
I01-2008,
I06-0160,
SR-01000076216-5,
SR-01000076216-8,
BRD-A97674275-001-01-9,
BRD-A97674275-001-04-3,
Z68563450,
(+/-)-4-(2-Hydroxy-3-(o-methoxyphenoxy)propyl)-1-piperazineaceto-2',6'-xylidide,
(+-)-N-(2,6-Dimethylphenyl)-4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)-1-piperazineacetamide,
(+/-)-1-(3-(2-Methoxyphenoxy)-2-hydroxypropyl)-4-(n-(2,6-dimethylphenyl)carbamoylmethyl)piperazine,
1-[3-(2-methoxyphenoxy)-2-hydroxypropyl]-4-[(2,6-dimethylphenyl)aminocarbonylmethyl]piperazine,
1-Piperazineacetamide, N-(2,6-dimethylphenyl)-4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)-, (+-)-,
110445-25-5,
N-(2,6-Dimethyl-phenyl)-2-{4-[2-hydroxy-3-(2-methoxy-phenoxy)-propyl]-piperazin-1-yl}-acetamide,
N-(2,6-dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl}ethanimidic acid,
Ranolazine 2HCl,
Ranolazine dihydrochloride,
metoprolol,
renexa,
renolazine,
Ranolazine HCl,
Ranolazine 1g,
Ranolazine-d3,
Ranexa, Ranolazine,
( -)-Ranolazine,
Ranolazine [USAN],
Ranolazine hydrochloride,
UNII-A6IEZ5M406,
D03HYQ,
D06TES,
A6IEZ5M406,
RS-43285,
CID56959,
sodium 3,5-dicarboxybenzenesulfonate,
C24-H33-N3-O4,
CS-T-41527,
RS 43285,
2451B,
Ranolazine/Dronedarone Fixed-Dose Combination,
A11162,
RS 43285-193,
C055512,
95635-56-6,
(+-)-4-[2-hydroxy-3-(o-methoxyphenoxy)propyl]-1-piperazineaceto-2',6'-xylidide,
37350-58-6,
|
| Complexity | 531 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 427.247g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 31 |
| Hydrogen Bond Acceptor Count | 6 |
| Hydrogen Bond Donor Count | 2 |
| Isotope Atom Count | 0 |
| Molecular Weight | 427.545g/mol |
| Monoisotopic Mass | 427.247g/mol |
| Rotatable Bond Count | 9 |
| Topological Polar Surface Area | 74.3A^2 |
| Undefined Atom Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 2.7 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302-H315-H319-H332-H335 |
| Packing Group | |
| Precautionary statements | P261-P280-P305+P351+P338 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

